Cargando…
Adapting an Expanded Access program to enable investigational treatments for COVID-19
Retrospective case studies of initiatives supported by the National Institutes of Health’s Clinical and Translational Science Award (CTSA) hubs can be used to identify facilitators and barriers of translational science. This case study investigates how a CTSA Expanded Access program adapted to chang...
Autores principales: | Samuels, Elias, Champagne, Ellen, Gravelin, Misty, Racklyeft, Jamie, Weatherwax, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274384/ https://www.ncbi.nlm.nih.gov/pubmed/35836783 http://dx.doi.org/10.1017/cts.2022.403 |
Ejemplares similares
-
400 Exploring the Diversity of Expanded Access Patients at Michigan Medicine
por: Gravelin, Misty, et al.
Publicado: (2023) -
2276 Development of the expanded access oversight committee at Michigan Medicine
por: Weatherwax, Kevin, et al.
Publicado: (2018) -
Right now, in the right way: U. S. Food and Drug Administration’s expanded access program and patient rights
por: Holbein, M. E. Blair, et al.
Publicado: (2018) -
National landscape assessment of academic medical center support for expanded access to investigational products
por: Gravelin, Misty, et al.
Publicado: (2022) -
Real-World Data Collection from Expanded Access Case Studies for the Treatment of Nontuberculous Mycobacterial Infection with Clofazimine
por: Gravelin, Misty, et al.
Publicado: (2023)